Axogen director plans sale of 3,500 shares

Axogen, Inc. (AXGN) director Joseph A. Tyndall filed a Form 144 notice for a proposed sale of up to 3,500 shares of Axogen common stock.

Rhea-AI Filing Summary

Axogen, Inc. (AXGN) director Joseph A. Tyndall filed a Form 144 notice for a proposed sale of up to 3,500 shares of Axogen common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $174,580 on NASDAQ as of September 2, 2026.

The 3,500 shares relate to Axogen common stock acquired on June 19, 2026 via Restricted Stock Units from the issuer. Form 144 is a notice of proposed sale under Rule 144 and does not itself confirm that the sale has occurred.

Key Figures

Shares proposed for sale: 3,500 shares Aggregate market value: $174,580 Acquisition date of securities: June 19, 2026 +2 more

5 metrics

Shares proposed for sale 3,500 shares Common stock covered by the Form 144 notice

Aggregate market value $174,580 Value referenced for the 3,500 shares of common stock

Acquisition date of securities June 19, 2026 Date the common stock was acquired via Restricted Stock Units

Trading market NASDAQ Market identified for the proposed sale of Axogen common stock

Signature date September 2, 2026 Date associated with the Form 144 signed by Joseph A. Tyndall

Key Terms

Rule 144, Restricted Stock Units, person for whose account the securities are to be sold

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 06/19/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

person for whose account the securities are to be sold regulatory

"Name of Person for Whose Account the Securities are To Be Sold"

FAQ

What does the Form 144 filing for AXGN disclose about Joseph A. Tyndall?

The filing states that director Joseph A. Tyndall submitted a Form 144 notice for a proposed sale of Axogen, Inc. common stock for his account under Rule 144.

How many Axogen (AXGN) shares are covered by Joseph A. Tyndall’s Form 144?

The notice covers a proposed sale of up to 3,500 shares of Axogen, Inc. common stock, with an indicated aggregate market value of $174,580 as referenced in the filing.

What type of Axogen (AXGN) securities is Joseph A. Tyndall proposing to sell?

The Form 144 relates to Axogen common stock that was acquired via Restricted Stock Units. The securities section identifies the security type as common and the form of acquisition as Restricted Stock Units from the issuer.

When were the Axogen (AXGN) shares in Joseph A. Tyndall’s Form 144 acquired?

The shares referenced in the Form 144 were acquired on June 19, 2026 through Restricted Stock Units granted by Axogen, Inc.

On which market are the AXGN shares in Joseph A. Tyndall’s Form 144 intended to be sold?

The Form 144 identifies NASDAQ as the market for the proposed sale of Axogen, Inc. common stock covered by the notice.

Which broker is listed in the AXGN Form 144 for Joseph A. Tyndall’s proposed sale?

The proposed sale of Axogen common stock is listed as being through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:33 PM Accepted by SEC EDGAR 09/02/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001955281
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Axogen, Inc.
SEC File Number	001-36046
Address of Issuer	13631 Progress Blvd., Suite 400 Alachua FLORIDA 32615
Phone	3864626800
Name of Person for Whose Account the Securities are To Be Sold	JOSEPH A TYNDALL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3500	174580.00	53761513	09/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/19/2026	Restricted Stock Units	Issuer			3500	06/19/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joseph A Tyndall
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)